Pharmaceutical Product Development, Inc. · Wilmington, NC United States ·(NASDAQ (GS): PPDI)
Company Description
- S&P 400
This link will open in a new window Pharmaceutical Product Development (PPD) is in the hunt for newfangled drugs. One of the world's largest contract research organizations (CROs), PPD provides global research and development services to pharmaceutical, biotech, and medical device companies seeking regulatory approval for their products. The company offers a broad range of services, from toxicology testing and biomarker discovery in the earliest phases of drug research, to the management of large, multi-site clinical trials, in which drug compounds are tested in human subjects. PPD is also developing some of its own compounds in partnership with other firms. Its customers have included most of the world's top 50 pharmaceutical companies. To read the full description, subscribe now.
Key Pharmaceutical Product Development, Inc. Financials
| Company Type | Public - NASDAQ (GS): PPDI Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $1,569.9 |
| 2008 Employees | 10,500 |
Pharmaceutical Product Development, Inc. Executives
| Title | Name & Bio | Contact |
| Chairman | Fredric Eshelman | Network |
| CEO and Director | David Grange | Network |
| COO | William Sharbaugh | Network |